首页 › 基金 › BIT Capital GmbH › IMNM

BIT Capital GmbH 对 IMNM 的持仓历史

IMMUNOME INC · 医疗保健

BIT Capital GmbH 在 Q3 2026 的 13F 申报中披露持有 IMNM(IMMUNOME INC)83,400 股,市值约 US$1.8M,约占其申报组合的 0.08%,在其申报持仓中市值排名第 46 位。 BIT Capital GmbH 最近 5 个申报季度中有 3 个季度披露了 IMNM 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q3 2026)83.40K 股
申报持仓市值$1.79M
组合权重0.08%
首次申报Q3 2025
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

BIT Capital GmbH 对 IMNM 的持仓演变

BIT Capital GmbH 于 Q3 2025 首次披露 IMNM 持仓:5,927 股(约 US$69K)。 该持仓在 Q3 2026 达到峰值 83,400 股,市值约 US$1.8M。 在 3 次申报中,BIT Capital GmbH 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 83,400 股、市值约 US$1.8M。

逐季持仓明细

季度股数金额变化
Q3 2025 5.93K $69.41K 新进
Q2 2026 83.40K $1.77M 新进
Q3 2026 83.40K $1.79M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IMNM 与 13F 数据

IMNM(IMMUNOME INC)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 IMNM,申报仓位最大的包括:Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$45.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IMNM 的基金

查看 IMNM 的全部基金持有人 →

常见问题

How long has BIT Capital GmbH held IMNM?

BIT Capital GmbH has disclosed IMNM holdings in 3 of the last 5 reported quarters, going back to Q3 2025.

What is BIT Capital GmbH's current position in IMNM?

As of Q3 2026, BIT Capital GmbH holds 83.40K shares of IMNM (IMMUNOME INC), valued at $1.79M, representing 0.08% of its reported portfolio and ranking #46.

Has BIT Capital GmbH been buying or selling IMNM?

In the latest 13F filing (Q3 2026), BIT Capital GmbH held unchanged its position in IMNM. The position peaked in Q3 2026 at 83.40K shares.

Which other funds hold IMNM?

Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.